Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8862276rdf:typepubmed:Citationlld:pubmed
pubmed-article:8862276lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:8862276lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:8862276lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:8862276lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:8862276lifeskim:mentionsumls-concept:C1422036lld:lifeskim
pubmed-article:8862276lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:8862276lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:8862276lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:8862276lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:8862276pubmed:issue2lld:pubmed
pubmed-article:8862276pubmed:dateCreated1996-12-9lld:pubmed
pubmed-article:8862276pubmed:abstractTextThe human T-lymphoid cell line, CEM, was transfected with gp 160 cDNA of human immunodeficiency virus type 1 (HIV-1)pm213. Three clones expressing the envelope glycoproteins (env), designated CEM-213env1, -env4, and -env7, were isolated. These clones expressed high levels of surface gp41 and gp120, as demonstrated by flow cytometry with anti-HIV env monoclonal antibodies. Processing and function of env was shown by induction of syncytia with CD4-expressing HeLa cells and by immunoblot analysis. The env expression resulted in specific down-regulation of surface CD4 levels, supporting the role of HIV env in CD4 modulation. Furthermore, serum samples from nine of nine HIV-1-infected individuals bound specifically to the env-expressing transfectants, substantiating the presence of conserved antigenic determinants. These sera also mediated antibody-dependent cellular cytotoxicity (ADCC) of the env-expressing cell lines. The env-expressing cell lines provide a relevant, safe, and practical model for qualitative and quantitative analysis of humoral and cellular immune responses and their role in HIV-1 pathogenesis and therapy.lld:pubmed
pubmed-article:8862276pubmed:languageenglld:pubmed
pubmed-article:8862276pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8862276pubmed:citationSubsetIMlld:pubmed
pubmed-article:8862276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8862276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8862276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8862276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8862276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8862276pubmed:statusMEDLINElld:pubmed
pubmed-article:8862276pubmed:monthOctlld:pubmed
pubmed-article:8862276pubmed:issn1077-9450lld:pubmed
pubmed-article:8862276pubmed:authorpubmed-author:CloydM WMWlld:pubmed
pubmed-article:8862276pubmed:authorpubmed-author:LiHHlld:pubmed
pubmed-article:8862276pubmed:authorpubmed-author:FeeW WWWlld:pubmed
pubmed-article:8862276pubmed:authorpubmed-author:KelerTTlld:pubmed
pubmed-article:8862276pubmed:authorpubmed-author:VitaleL ALAlld:pubmed
pubmed-article:8862276pubmed:issnTypePrintlld:pubmed
pubmed-article:8862276pubmed:day1lld:pubmed
pubmed-article:8862276pubmed:volume13lld:pubmed
pubmed-article:8862276pubmed:ownerNLMlld:pubmed
pubmed-article:8862276pubmed:authorsCompleteYlld:pubmed
pubmed-article:8862276pubmed:pagination117-26lld:pubmed
pubmed-article:8862276pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:meshHeadingpubmed-meshheading:8862276-...lld:pubmed
pubmed-article:8862276pubmed:year1996lld:pubmed
pubmed-article:8862276pubmed:articleTitleDevelopment of T-cell lines expressing functional HIV-1 envelope glycoproteins for evaluation of immune responses in HIV-infected individuals.lld:pubmed
pubmed-article:8862276pubmed:affiliationMedarex, Inc., Annandale, New Jersey 08801, USA.lld:pubmed
pubmed-article:8862276pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8862276pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:920entrezgene:pubmedpubmed-article:8862276lld:entrezgene
entrez-gene:155971entrezgene:pubmedpubmed-article:8862276lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:8862276lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:8862276lld:entrezgene